Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry

Reuters Events 11 - 22 October, 2021, Virtual
Board level executives from Novartis, Bayer and Boehringer Ingelheim, amongst many more, will showcase their long-term visions for healthcare as a response to the COVID-19 pandemic, by joining the speaker faculty at Reuters Events Pharma Europe 2021.

Reuters Events will bring together another 150 life sciences leaders as speakers, and thousands more executive attendees, to showcase the investments being made as the industry accelerates its digital transformation platform to ensure changes are embedded for long-term value for physicians and patients alike.

Blair Gottscho, Managing Director - Pharma, Reuters Events, said the pharma industry had responded well to the challenges of the pandemic, re-assessed operating models, and have found new ways to deliver for physicians, clinicians, providers, payers and patients alike.

"There is significant investment happening across the industry - in both people and technology - to create long-lasting, integrated and flexible systems and processes, that are helping to build a more sustainable healthcare systems.

"We're proud to be showcasing the best and brightest at Pharma Europe 2021. This is the global home for industry executives to set strategy post-pandemic.” Along with this investment, the industry is experiencing an acceleration in collaboration between functions within organizations. However, the environment for collaboration extends beyond company walls, as companies are increasingly forming partnerships that build value for all healthcare stakeholders.

Josh Bramwell, Head of Europe, Reuters Events, said the industry had stepped up to the challenges that the pandemic has created.

“Companies are now seeing collaboration as a competitive advantage," Bramwell said.

"They've looked to optimise pre-competitive opportunities with industry partners, foster long-term stakeholder partnerships to provide real-world patient value, and remove function silos to deliver an agile and efficient business model. These are the case studies that we'll be highlighting on stage at Pharma Europe 2021."

Reuters Events Pharma Europe has been running for 18 years and was previously known as eyeforpharma Barcelona.

You can learn more about Pharma Europe here: https://reutersevents.com/events/barcelona/

Most Popular Now

Lilly and Lycia Therapeutics enter into strategic …

Eli Lilly and Company (NYSE: LLY) and Lycia Therapeutics, Inc. today announced a multi-year research collaboration and licensing agreement focused on the discovery, devel...

SK bioscience and GSK start Phase 3 trial of adjuv…

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of a Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination wit...

Blood vessels produce growth factor that promotes …

Blood vessels supply tumors with nutrients and, on the other hand, enable cancer cells to spread throughout the body. The settlement of circulating tumor cells in a dista...

New study examines 'Achilles heel' of cancer tumou…

Researchers at the University of British Columbia's faculty of medicine and BC Cancer Research Institute have uncovered a weakness in a key enzyme that solid tumour cance...

AI algorithm solves structural biology challenges

Determining the 3D shapes of biological molecules is one of the hardest problems in modern biology and medical discovery. Companies and research institutions often spend ...

No serious health effects linked to mRNA COVID-19 …

Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 v...

A drug costing less than €2 a day helps in the tre…

Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients. This is the finding of a study by investigators at th...

Rheumatoid arthritis treated with implanted cells …

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically ...

Gut bacteria and flavonoid-rich foods are linked a…

Flavonoid-rich foods, including berries, apples, pears and wine, appear to have a positive effect on blood pressure levels, an association that is partially explained by ...

First-in-human clinical trial for a vaccine to tre…

The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by resear...

One in three Americans had COVID-19 by the end of …

A new study published in the journal Nature estimates that 103 million Americans, or 31 percent of the U.S. population, had been infected with SARS-CoV-2 by the end of 20...

Sandoz strengthens pipeline by entering into agree…

Sandoz, a Novartis division, today announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706). B...